C-Suite

Five things for pharma marketers to know: Wednesday, January 24, 2018

Five things for pharma marketers to know: Wednesday, January 24, 2018

By

Novartis sees single-digit growth with new CEO; J&J takes $13.6b charge in the wake of the new tax law; New York City invests in biotech

Flexion's pivot proves pain-free

Flexion's pivot proves pain-free

By

Clayman says the company's next 18 months are all about Zilretta, with further pipeline construction next up.

Nick Law quits R/GA for lead creative role across Publicis Groupe

Nick Law quits R/GA for lead creative role across Publicis Groupe

By

Nick Law, the global chief creative officer of R/GA, is leaving the company after 17 years to take on the newly created role of chief creative officer across Publicis Groupe and president of Publicis Communications.

Why Greater Than One's Elizabeth Apelles stands firm on independence

Why Greater Than One's Elizabeth Apelles stands firm on independence

By

The CEO of the independent healthcare agency discusses growing a business in digital in the early 2000s and the perks of remaining independent.

McCann Health promotes Marcus Sigurdsson to global chief digital officer

McCann Health promotes Marcus Sigurdsson to global chief digital officer

By

Sigurdsson is charged with leading the agency's digital offering to meet growing client demand.

Five things for pharma marketers to know: Friday, January 12, 2018

Five things for pharma marketers to know: Friday, January 12, 2018

By

Pharma looks to Spark for pricing blueprint; Ipsen hires Amgen exec as CEO of North America; FDA could improve social-media approach, study finds

Five things for pharma marketers to know: Thursday, January 11, 2018

Five things for pharma marketers to know: Thursday, January 11, 2018

By

Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations

Day 2 at JP Morgan '18: Pharma's need for more diversity and data sharing grab the spotlight

Day 2 at JP Morgan '18: Pharma's need for more diversity and data sharing grab the spotlight

By

A plea for IT interoperability and a stinging criticism of the pharma industry over its lack of diversity were two highlights of yesterday's events.

Day 1 at JP Morgan '18: Easier access to cash spells more M&A, say pharma CEOs

Day 1 at JP Morgan '18: Easier access to cash spells more M&A, say pharma CEOs

By

How drugmakers should prepare for and respond to the forces poised to reshape the industry was a popular topic on day one of the 36th annual JP Morgan Healthcare Conference.

Five things for pharma marketers to know: Monday, January 8, 2018

Five things for pharma marketers to know: Monday, January 8, 2018

By

Celgene to buy Impact Biomedicines for up to $7 billion; Pfizer plans to cut 300 positions in neuroscience; Perrigo hires new CEO

MM&M's 5 most-read agency stories of 2017

MM&M's 5 most-read agency stories of 2017

By

The agency issue, people moves, and a series of restructures top the list.

Merck comms head Adele Ambrose to retire

Merck comms head Adele Ambrose to retire

By

VP of investor relations Teri Loxam will take over Ambrose's role in January.

Ironwood strengthens leadership with two new hires

Ironwood strengthens leadership with two new hires

By

The drugmaker named William Huyett as COO and Gina Consylman as SVP and CFO.

Amarin's Salyer preps for Vascepa push

Amarin's Salyer preps for Vascepa push

By

Whatever REDUCE-IT ultimately reveals (results from the completed study are expected in Q2 or Q3 2018), Salyer maintains Amarin has "a great story to tell, with or without the data."

Publicis.Sapient's Alan Wexler steps up as digital chief Chip Register retires

Publicis.Sapient's Alan Wexler steps up as digital chief Chip Register retires

By

Publicis Groupe has named Alan Wexler as chief executive of Publicis.Sapient as Chip Register has chosen to retire at the end of the year.

How working with Apple inspired Jeff Tangney to found Doximity

How working with Apple inspired Jeff Tangney to found Doximity

By

The CEO's experience launching medical reference app Epocrates led him to found a social network for physicians.

Five things for pharma marketers to know: Tuesday, November 14, 2017

Five things for pharma marketers to know: Tuesday, November 14, 2017

By

FDA approves first digital pill; biotech companies race to develop cancer-fighting microbiome drugs; Loxo and Bayer reach $1.55 billion deal for rare cancer drugs

Omnicom promotes Biolumina and H&S presidents to CEO

Omnicom promotes Biolumina and H&S presidents to CEO

By

Ty Curran, previously CEO of the sister agencies, will serve as chairman in 2018.

Maurice Lévy on his 30 years in charge of Publicis Groupe

Maurice Lévy on his 30 years in charge of Publicis Groupe

By

Midway through Campaign's audience with Publicis Groupe's Maurice Lévy, a heavily French-accented voice exclaims, "Now it is time for the real boss to arrive."

10 questions for PhRMA's CEO Stephen Ubl

10 questions for PhRMA's CEO Stephen Ubl

By

Trade group PhRMA's CEO talks about his first year in the job amid public outrage about price gouging.

The professional paths of 8 pharma execs

The professional paths of 8 pharma execs

By

The successes of these pharma execs show that there's no one path to professional bliss.

Memo to New CEOs: Prioritize Diversity

Memo to New CEOs: Prioritize Diversity

By

Management turnover has brought the opportunity to keep up the pressure.

At ADCOLOR, Five Woke Women challenge perceptions of identity in the workplace

At ADCOLOR, Five Woke Women challenge perceptions of identity in the workplace

By

A "seat at the table" isn't enough, says Oath's Allison Allen, in wide-ranging discussion at annual diversity conference.

Q&A: On being a working mom

Q&A: On being a working mom

Guidemark Health's Tina Fascetti offers Medela's Katie Busse advice on being a working mother in healthcare marketing.

The Medicines Company appoints former Biogen exec to lead commercial activities

The Medicines Company appoints former Biogen exec to lead commercial activities

By

Tony Kingsley will oversee the company's daily operations and commercial activities.

Five things for pharma marketers to know: Monday, March 21, 2016

Five things for pharma marketers to know: Monday, March 21, 2016

By

Pearson to be replaced at Valeant; Pfizer's Xeljanz meets Phase III goals; Harvard partners with Merck on leukemia drug development

From One CMO to Another: What Chief Medical Officers Can Learn from Chief Marketing Officers

From One CMO to Another: What Chief Medical Officers Can Learn from Chief Marketing Officers

By thinking like marketers, chief medical officers can embrace innovation and differentiate their organizations by providing better experiences, better products and ultimately better health.